5 THINGS TO KNOW ABOUT
DSIP (Emideltide)
The “deep sleep” peptide the FDA panel voted against
A peptide is a tiny chain of protein building blocks your body also makes.


Betty: Hi! I’m Betty. DSIP is short for delta sleep-inducing peptide — maybe the best name in the whole peptide world. “Delta sleep” means the deepest, most restful stage of sleep, so the name basically promises a good night’s rest in a bottle. Here’s the twist: scientists first spotted it while studying sleeping brains back in the 1970s, and fifty years later they still cannot agree that it does what its name says. Best name in peptides, weakest track record.

Ace: Here is the science, kept simple. Your deepest, most healing sleep is called delta sleep — the slow, dreamless kind where your body does its overnight repairs. DSIP got its name because early studies hinted it could nudge the brain into more of that deep stage. The honest catch: when other scientists ran the same test, some saw a little more deep sleep and others saw none at all. In 2006, a review paper gave up trying to settle it and flat-out called DSIP “a still unresolved riddle”3. Fifty years of homework, and the riddle is still open.

Betty: So here is the honest bottom line. DSIP has the dreamiest name of the bunch, but of the 7 peptides the FDA’s expert panel reviewed in July 2026, it was the only one voted down, 6 to 7.1 A great name still could not crack a 50-year-old riddle. Nothing is final yet — but if sleep is a real problem, a doctor is the best place to start, not a bottle from the internet.
02
How It Works
So what is it actually supposed to do?
Named for delta sleep — the deep, dreamless stage where your body does its overnight repairs
The idea was simple: signal the brain to spend more time down in that deep stage

But no one ever pinned down exactly how it does that inside the body
And even after 50 years, strong studies in people stayed rare2
03
What the Research Shows
Here is the honest part — the studies never agreed.
Sleep-study results have been inconsistent since the 1970s3

Mixed
results across the sleep studies to date
04
What It’s Explored For
The short list of things scientists have poked at.
One to watch, not to try
DSIP (emideltide) is an experimental peptide, not approved as a medicine — and the FDA’s expert advisers voted against letting pharmacies make it. We will update this page as the rules evolve.
Browse our peptide guides →Sources 1. FDA: July 2026 Pharmacy Compounding Advisory Committee meeting · 2. PNAS 1977: first description of the delta sleep-inducing peptide · 3. J Neurochem 2006: DSIP, a still unresolved riddle · 4. Neuropsychobiology 1983: DSIP and opiate withdrawal · 5. NIH NCATS: Emideltide (investigational)
Important: This page is for education only and is not medical advice. DSIP (Emideltide) is not FDA-approved and is not on the FDA 503A compounding list (the FDA’s list of ingredients pharmacies are allowed to mix into custom medicines). Most research is early, done in labs and animals, with limited reliable human data. In July 2026, a group of outside experts who advise the FDA voted against letting pharmacies make it, and FDA staff agreed. That vote is advice only. The FDA has not made its official final decision as of August 2026, so this could still change. Nothing here is an offer to sell or a recommendation to use DSIP (Emideltide).
Different peptides, different jobs. Which one are you trying to learn about?
Not sure? Take the 60-second quiz →

Comments